4//SEC Filing
Ballance David James 4
Accession 0001209191-19-015025
CIK 0001169245other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:44 PM ET
Size
5.7 KB
Accession
0001209191-19-015025
Insider Transaction Report
Form 4
Ballance David James
VP, Research and Sci. Affairs
Transactions
- Award
Employee Stock Option (right to buy)
2019-02-27+45,000→ 45,000 totalExercise: $3.15Exp: 2029-02-27→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in equal monthly installments over 48 months from February 27, 2019, subject to the reporting person's continued service through each such date.
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001755432
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:44 PM ET
- Size
- 5.7 KB